<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01453244</url>
  </required_header>
  <id_info>
    <org_study_id>11-037</org_study_id>
    <nct_id>NCT01453244</nct_id>
  </id_info>
  <brief_title>Pharmacogenomic Research in Korean Patients With Hepatitis C</brief_title>
  <official_title>Pharmacogenomic Research for Prediction of Drug Response in Korean Patients With Hepatitis C</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Inje University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Inje University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to investigate the relationships between drug response and the host
      genetic factors, viral factors and clinical factors in chronic hepatitis C patients (HCV).
      And thus, the investigators are trying to develop the pharmacogenomic guideline in the Korean
      patients with HCV.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2011</start_date>
  <completion_date type="Actual">March 2013</completion_date>
  <primary_completion_date type="Actual">March 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
  </study_design_info>
  <primary_outcome>
    <measure>Sustained virological response (SVR)</measure>
    <time_frame>24 weeks after the end of treatment</time_frame>
    <description>Undetectable HCV RNA in serum ( &lt;15 IU/ml ) 24 weeks after the end of treatment</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Anemia</measure>
    <time_frame>4 weeks after start of treatment</time_frame>
    <description>a reduction in Hemoglobin of &gt;3.0 g/dL
a reduction in Hemoglobin levels to 10.0g/dL.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">373</enrollment>
  <condition>Chronic Hepatitis C</condition>
  <arm_group>
    <arm_group_label>SVR group</arm_group_label>
    <description>A patients who achieved SVR (sustained virologic response)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>non-SVR group</arm_group_label>
    <description>A patients who not achieved SVR (sustained virologic response)</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      DNA extracted from blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Korean patients with chronic hepatitis C
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Hepatitis C virus infected patients

        Exclusion Criteria:

          -  Patients who infected Hepatitis B virus or Human immunodeficiency virus

          -  HCV infected patients previously treated with antiviral drugs

          -  Patients had a history of autoimmune hemolytic anemia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jae-Gook Shin, M.D, phD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Inje University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Inje University</name>
      <address>
        <city>Busan</city>
        <zip>633-165</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>May 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 13, 2011</study_first_submitted>
  <study_first_submitted_qc>October 14, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 17, 2011</study_first_posted>
  <last_update_submitted>May 30, 2013</last_update_submitted>
  <last_update_submitted_qc>May 30, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 3, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Inje University</investigator_affiliation>
    <investigator_full_name>Jae-Gook Shin</investigator_full_name>
    <investigator_title>Jae-Gook Shin</investigator_title>
  </responsible_party>
  <keyword>Chronic hepatitis C</keyword>
  <keyword>Pharmacogenomics</keyword>
  <keyword>IL28B</keyword>
  <keyword>ITPA</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hepatitis</mesh_term>
    <mesh_term>Hepatitis A</mesh_term>
    <mesh_term>Hepatitis C</mesh_term>
    <mesh_term>Hepatitis, Chronic</mesh_term>
    <mesh_term>Hepatitis C, Chronic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

